List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 12 studies with search of: "Vidarabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
Conditions: Herpes Simplex;   HIV Infections
Interventions: Drug: Vidarabine;   Drug: Acyclovir;   Drug: Foscarnet sodium
2 Recruiting Low-Dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Conditions: Cancer;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Clofarabine
3 Recruiting Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Condition: B-Cell Lymphoma
Intervention: Drug: Clofarabine
4 Active, not recruiting Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
Conditions: Acute Leukaemia;   Chronic Disease;   Leukemia;   Myelodysplasia;   Lymphoma
Interventions: Drug: Busulfan;   Drug: Anti-Thymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclosporine;   Drug: Mycophenolate mofetil
5 Completed A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Fludarabine Phosphate (Fludara, BAY86-4864)
6 Active, not recruiting Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Biological: alemtuzumab;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
7 Active, not recruiting Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Drug: Rituximab
8 Completed Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
Condition: Lymphoma, Low-Grade
Intervention: Drug: Fludarabine phosphate
9 Completed Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL
Condition: Non Hodgkin Lymphoma
Intervention: Drug: Oral fludarabine phosphate
10 Recruiting Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: lenalidomide;   Drug: oral fludarabine phosphate
11 Active, not recruiting Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Intervention: Drug: fludarabine phosphate
12 Active, not recruiting Clofarabine in Chronic Lymphocytic Leukemia
Conditions: Hematologic Neoplasms;   Lymphoproliferative Disorders;   Leukemia;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: Clofarabine

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services